Moreover, it is necessary to consider a new class of drugs for T2DM, such as glucagon-like peptide 1 agonists that seem to have multiple actions in the central nervous system, including antidepressants that can affect the control of diabetes and depression. The gene discussed is GCG; the disease is depressive disorder.